Lumipulse® G CEA-N (Carcinoembryonic Antigen)
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of carcinoembryonic antigen (CEA) in serum or plasma.
The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
CE marked
Lumipulse® G CEA-N Immunoreaction Cartridges
Product number 292662
3 × 14 Tests
Please contact your local Fujirebio representative for the availability of this product in your country.
-
Details
Assay technology
CLEIA - ChemiLuminescent Enzyme Immunoassay
See the LUMIPULSE G1200 working in this video:
-
Documentation
Other documents
FileLumipulse G Lung Disease Management brochure.pdf (pdf, 151.32 kb)Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
Mesothelin, the novel, non-invasive in vitro biomarker to aid in the diagnosis of Mesothelioma
Mesothelioma is a rare form of cancer that is linked to exposure to asbestos. Although malignant mesothelioma remains a relatively uncommon malignancy...
Jun 6, 2019
-
Related products
-
Product inquiry
